Incheon
South Korea
3
2021-03-11
3
2024-04-23
These are the the leading inventors for applications assigned to Zymedi Co., Ltd.:
Zymedi Co., Ltd. based in Incheon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease
#2 | 2020-05-07 ✅ Patent 11,378,572 granted on 2022-07-05Therapeutic agent for immune cell migration-caused disease and method for screening same
#3 | 2020-04-02 ✅ Patent 11,685,791 granted on 2023-06-27Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane
Also check out ZYMEDI CO., LTD.'s (Incheon, South Korea) applicant profile with 3 patent applications submitted.
382052 ⎘